how long have glp-1 drugs been on the market Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Receptor Agonist Market Size

Identifying inflammation early may help prevent the progression of these diseases

coli and structurally characterized by CD spectroscopy and molecular modeling [42]

India is home to over 100 million people with diabetes and approximately 250 million classified as obese or overweight.[15] What makes the situation uniquely dangerous is the Thin-Fat Indian paradox: South Asians tend to accumulate more visceral (belly) fat, liver fat, and less lean muscle mass at lower body weights than Western populations.[8][9][10] While GLP-1 medications are a global phenomenon, they are particularly critical for the Thin-Fat Indian phenotype

Most patients at Perfect B see meaningful results from either protocol within two months, roughly two full treatment cycles

Red line : Its the junction between wet and dry vermillion mucosa